We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+24.56%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$467B
AUM Growth
+$83.7B
Cap. Flow
+$2.63B
Cap. Flow %
0.56%
Top 10 Hldgs %
22.59%
Holding
4,219
New
118
Increased
2,550
Reduced
1,055
Closed
119

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$524M
2
META icon
Meta Platforms (Facebook)
META
+$458M
3
OTIS icon
Otis Worldwide
OTIS
+$345M
4
TMUS icon
T-Mobile US
TMUS
+$307M
5
ABBV icon
AbbVie
ABBV
+$280M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$878M
2
RTN
Raytheon Company
RTN
+$537M
3
BMY icon
Bristol-Myers Squibb
BMY
+$435M
4
AAPL icon
Apple
AAPL
+$389M
5
ACN icon
Accenture
ACN
+$216M

Sector Composition

Rank Sector Weight
1 Technology 23.72%
2 Healthcare 14.52%
3 Financials 12.98%
4 Consumer Discretionary 10.98%
5 Communication Services 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPIX icon
3676
Cumberland Pharmaceuticals
CPIX
$100M
$173K ﹤0.01%
52,117
+3,507
+7% +$12.8K
CHAP
3677
DELISTED
Chaparral Energy, Inc.
CHAP
$171K ﹤0.01%
264,012
-185,422
-41% -$97.6K
CMT icon
3678
Core Molding Technologies
CMT
$202M
$169K ﹤0.01%
41,150
KPRX icon
3679
Kiora Pharmaceuticals
KPRX
$11.3M
$168K ﹤0.01%
97
+1
+1% +$1.88K
PDSB icon
3680
PDS Biotechnology
PDSB
$38.4M
$168K ﹤0.01%
83,909
+65,773
+363% +$73.2K
SWIR
3681
DELISTED
Sierra Wireless
SWIR
$168K ﹤0.01%
18,794
RNTX
3682
Rein Therapeutics
RNTX
$63.1M
$167K ﹤0.01%
7,089
+1,555
+28% +$25.3K
VIRX
3683
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$167K ﹤0.01%
18,194
SHLO
3684
DELISTED
Shiloh Industries Inc
SHLO
$167K ﹤0.01%
103,463
DALN
3685
DELISTED
DallasNews
DALN
$166K ﹤0.01%
23,993
-1,838
-7% -$11.7K
CSWC icon
3686
Capital Southwest
CSWC
$1.47B
$165K ﹤0.01%
+12,254
New +$158K
NGD
3687
DELISTED
New Gold Inc
NGD
$165K ﹤0.01%
122,409
QUIK icon
3688
QuickLogic
QUIK
$232M
$165K ﹤0.01%
54,054
UXIN
3689
Uxin Ltd
UXIN
$306M
$164K ﹤0.01%
1,149
+114
+11% +$17.1K
SIOX
3690
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$164K ﹤0.01%
58,313
+14,088
+32% +$45.2K
BNGO icon
3691
Bionano Genomics
BNGO
$12.3M
$163K ﹤0.01%
535
+123
+30% +$30.9K
DXLG icon
3692
Destination XL Group
DXLG
$31.2M
$163K ﹤0.01%
250,764
FTEK icon
3693
Fuel Tech
FTEK
$43.9M
$162K ﹤0.01%
193,817
PHUN icon
3694
Phunware
PHUN
$43.1M
$162K ﹤0.01%
2,648
-2,030
-43% -$96.9K
KEP icon
3695
Korea Electric Power
KEP
$15.3B
$161K ﹤0.01%
20,250
+8,198
+68% +$71.1K
TTPH
3696
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$161K ﹤0.01%
64,092
+22,353
+54% +$42.4K
ATAXZ
3697
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$161K ﹤0.01%
39,141
HYMCW
3698
DELISTED
Hycroft Mining Holding Corporation Warrant
HYMCW
$160K ﹤0.01%
+121,400
New +$132K
KNDI
3699
Kandi Technologies Group
KNDI
$67.5M
$160K ﹤0.01%
38,330
OPRA
3700
Opera Ltd
OPRA
$1.69B
$160K ﹤0.01%
17,810

Similar funds

Geode Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
  • Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
  • Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
  • Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
  • Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
  • Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
  • Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.

Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.